Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Cohen

Showing results (61-70 of 217) with videos related to

Pageof 22
Sort By:
The American Journal of Psychiatry|November 1, 1981
Haloperidol levels and clinical responseB M Cohen, R J Baldessarini
Psychopharmacology Bulletin|January 1, 1985
Relevance of genetic variability to clinical psychopharmacologyB M Cohen, G S Zubenko
The American Journal of Psychiatry|April 1, 1985
Tolerance to therapeutic effects of antidepressantsB M Cohen, R J Baldessarini
Life Sciences|December 29, 1986
In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of actionB M Cohen, J F Lipinski
Life Sciences|October 14, 1985
Aging and the biophysical properties of cell membranesB M Cohen, G S Zubenko
Respiration; International Review of Thoracic Diseases|January 1, 1982
Acute aromatics inhalation modifies the airways. Effects of the common coldB M Cohen, W E Dressler
Biological Psychiatry|April 1, 1985
Effects of phenothiazine treatment on the physical properties of platelet membranes from psychiatric patientsG S Zubenko, B M Cohen
Psychopharmacology|January 1, 1986
A cell membrane correlate of tardive dyskinesia in patients treated with phenothiazinesG S Zubenko, B M Cohen
Journal of Clinical Psychopharmacology|April 1, 1988
Captopril in the treatment of recurrent major depressionB M Cohen, G S Zubenko
Neuroscience|June 20, 2006
Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatumJ Ma, N Ye, B M Cohen
Pageof 22

Showing results (61-70 of 217) with videos related to

Sort By:
Pageof 22
The American Journal of Psychiatry|November 1, 1981
Haloperidol levels and clinical responseB M Cohen, R J Baldessarini
Psychopharmacology Bulletin|January 1, 1985
Relevance of genetic variability to clinical psychopharmacologyB M Cohen, G S Zubenko
The American Journal of Psychiatry|April 1, 1985
Tolerance to therapeutic effects of antidepressantsB M Cohen, R J Baldessarini
Life Sciences|December 29, 1986
In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of actionB M Cohen, J F Lipinski
Life Sciences|October 14, 1985
Aging and the biophysical properties of cell membranesB M Cohen, G S Zubenko
Respiration; International Review of Thoracic Diseases|January 1, 1982
Acute aromatics inhalation modifies the airways. Effects of the common coldB M Cohen, W E Dressler
Biological Psychiatry|April 1, 1985
Effects of phenothiazine treatment on the physical properties of platelet membranes from psychiatric patientsG S Zubenko, B M Cohen
Psychopharmacology|January 1, 1986
A cell membrane correlate of tardive dyskinesia in patients treated with phenothiazinesG S Zubenko, B M Cohen
Journal of Clinical Psychopharmacology|April 1, 1988
Captopril in the treatment of recurrent major depressionB M Cohen, G S Zubenko
Neuroscience|June 20, 2006
Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatumJ Ma, N Ye, B M Cohen
Pageof 22